Book Value per Share: 23andMe Inc. (ME)

Public company logo of 23andMe Holding Co (ME)

23andMe Holding Co. (ME) is overcoming a crisis of confidence and security challenges as it seeks to monetize the largest array of genomic data and CircleDNA test sales. The book value per common share reflects capital dynamics, where the value of 2.37 serves as the current metric. Meanwhile, 23andMe Holding Co. (ME) delegates cloud computing, logistics, and laboratory processing of biomaterials to external IT contractors and service partners.

23andMe Holding Co (ME) Equity per Share: for the period 07/04/2022 - 04/05/2025

Summary analytical data breakdowns for 23andme.com (ME)

- price and consensus price forecast:
Price Chart 23andMe Inc.|ME - Consensus Target
- market capitalization data:
Market Capitalization 23andMe Holding Co.|ME - Total Enterprise Value
- book capitalization data:
Book Value per Share 23andMe|ME - Accounting Capitalization|Market Capitalization to Book Value Ratio 23andme.com|ME - Company Total Assets
- debt and liquidity data:
Debt to Equity 23andMe Holding Co.|ME - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital 23andMe|ME - Company Aggregate Debts|Debt to Book Capitalization Ratio 23andMe Holding Co.|ME - Company Long-Term Debt|Company Current Liabilities 23andMe
Fundamental company valuation:ME - 23andMe Inc.
Manufactured product of 23andme.com

For 23andMe Holding Co. (ME), tangible laboratory assets are augmented by the value of the genome database, which is reflected in the trend of the book value per share. This indicator captures the difference between all of the issuer's assets and liabilities, determining the physical cost basis of a single share to assess the market discount and analyze business stagnation risks.

Competitor analysis

A: Net Assets per Single Share|DGX - Accounting Value per Share|Book Value per Share ILMN|exactsciences.com (EXAS) - Net Asset Value per Share|Book Value per Share Revvity (RVTY)|Equity per Share Bio-Rad Laboratories, Inc.|Book Value per Share NNNN|Book Value per Share SHC (Nordion)|QDEL - Net Assets per Single Share|Equity per Share opko.com OPK|CareDx, Inc - Book Value per Share|MRVI: Book Value per Share|Fulgent Corp (FLGT) - Net Assets per Single Share|Net Assets per Single Share Standard BioTools Corp|Accounting Value per Share CTKB (Cytek Biosciences, Inc.)|Net Asset Value per Share OSUR|XGN (Exagen Inc.) - Net Assets per Single Share|Net Assets per Share MDxHealth S.A. (MDXH)|Book Value per Share LUCD|Prenetics Global Limited - Net Assets per Share|Net Assets per Single Share IMDX (Insight Molecular)|TRIB: Net Assets per Share|PRPH (ProPhase Labs) - Net Assets per Single Share|Ainos Inc (AIMD) - Accounting Value per Share|CODX (Co-Diagnostics Corp) - Book Value per Share|Book Value per Share HSCS|Net Assets per Single Share Biomerica, Inc. BMRA|Equity per Share cardiodiagnosticsinc.com (CDIO)|VRAX - Book Value per Share|Bluejay Diagnostics Inc - Equity per Share|AWH: Net Assets per Single Share|AXDX - Accounting Value per Share|Book Value per Share CNTG|Net Asset Value per Share Enzo Biochem|FRES - Accounting Value per Share|Accounting Value of a Share GTG Labs|Psychemedics Corp (PMD) - Book Value per Share